Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Aytu BioScience, Inc.
Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility.
IPO Date: May 23, 2017
Sector: Healthcare
Industry: Pharma
Market Cap: $18.13M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.08 | 3.93%
Avg Daily Range (30 D): $0.08 | 4.51%
Avg Daily Range (90 D): $0.05 | 3.47%
Institutional Daily Volume
Avg Daily Volume: 1.58M
Avg Daily Volume (30 D): 2.16M
Avg Daily Volume (90 D): .76M
Trade Size
Avg Trade Size (Sh.): 479
Avg Trade Size (Sh.) (30 D): 222
Avg Trade Size (Sh.) (90 D): 223
Institutional Trades
Total Inst.Trades: 67
Avg Inst. Trade: $1.58M
Avg Inst. Trade (30 D): $.76M
Avg Inst. Trade (90 D): $.76M
Avg Inst. Trade Volume: .01M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.59M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 20.99K
   
News
Jul 17, 2024 @ 11:03 AM
Presenting on the Emerging Growth Conference 73 Da...
Source: N/A
Nov 15, 2023 @ 7:04 PM
Why Shapeways Holdings Shares Are Trading Lower By...
Source: Lisa Levin
Sep 28, 2023 @ 5:04 PM
Why CarMax Shares Are Trading Lower By Around 10%?...
Source: Lisa Levin
Sep 28, 2023 @ 3:55 PM
Best Penny Stocks? 4 Hot Stocks With News This Wee...
Source: J. Samuel
Aug 9, 2023 @ 3:00 PM
Benzinga's Top Ratings Upgrades, Downgrades For Au...
Source: Benzinga Insights
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $.2 $.65 $.13
Diluted EPS $.21 $-.26
Revenue $ 81.66M $ 18.45M $ 16.22M
Gross Profit $ 52.16M $ 12.81M $ 10.79M
Net Income / Loss $ 1.64M $ 3.99M $ .79M
Operating Income / Loss $ -6.14M $ 2.42M $ -1.7M
Cost of Revenue $ 29.5M $ 5.65M $ 5.44M
Net Cash Flow $ -1.59M $ -2.23M $
PE Ratio    
Splits
Jan 06, 2023:   1:20
Dec 09, 2020:   1:10
Aug 13, 2018:   1:20
Aug 29, 2017:   1:20
Jul 01, 2016:   1:12
Jun 10, 2015:   11:134